CDSCO
The Central Drugs Laboratories have identified 41 Drug Samples to be ‘Not of Standard Quality’ (NSQ) and State Drugs Testing Laboratories have identified 70 Drugs Samples as Not of Standard Quality (NSQ) for the month of Nov 2024.
Further, 2 drug samples have been identified as ‘spurious drugs’, out of 2 samples, 1 drug sample has been picked by Bihar Drugs Control Authority and 1 sample by CDSCO (NZ), Ghaziabad. The CDSCO said that these drugs have been made by unauthorized and unknown manufacturers, using brand names owned by other companies.
The CDSCO said an investigation has been initiated in the case.
“Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters. The failure is specific to the drug products of the batch tested by the Govt. Laboratory and it does not warrant any concerns on the other drug products available in the market”, said the CDSCO.
In a major advancement for the surgical landscape in India, Apollo Spectra Hospital has unveiled…
In an uncommon measure, doctors at a city hospital pulled off a 55-year patient with…
Rabies remains one of the most dangerous yet misunderstood viral diseases in the world. Despite…
Health experts have urged the public to clearly understand the difference between asthma-related breathing problems…
A three-day “Revision Arthroplasty Conference” (RAC 2025) which commenced on Friday in the national capital…
Under the Yellow Ribbon Campaign conceptualized in 1998 by Dr S K Sarin with the…